GSK PLC GSK shares inched up 0.20% to £15.31 Tuesday, on what proved to be an all-around favorable trading session for the ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...

Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

This tax demand was raised against HUL over non-deduction of TDS while making remittance payment for an acquisition from GSK ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...

Corporate sustainability leaders spoke about innovation and partnering with the public sector during a panel at the inaugural ...

EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

Wave Life Sciences stock surged over 50% today due to promising data from its Duchenne Muscular Dystrophy candidate WVE-N531.